nad+ and glp-1 together work differently. One approach may reduce caloric intake, while NAD+ supports mitochondrial function and healthy energy levels. Ask our pharmacist about your personalized wellness goals. Compounded medication. Not FDA-approved NAD+ vs. GLP-1… what's the

But certainly in patients who may have a greater level of obesity associated with their type 2 diabetes, perhaps initiating semaglutide before an SGLT2 inhibitor because of the weight benefit, the CV risk lowering, as well as the CKD benefit, may be appropriate. More screening needed Providers are hopeful the FLOW trial may raise greater awareness of CKD screening, particularly the measurement of UACR

The study was approved by the ethics committee of the University of Mainz

The better question is which one, or which combination, matches what you are trying to achieve

News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial